Related Experiment Video
Updated: Jan 3, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting
Jangus B Whitner1, Lisa A Mueller2, Alexa Sevin Valentino1,3
1PrimaryOne Health, Columbus, OH, USA.
Pharmacists proactively identifying high-risk patients for spirometry testing significantly increased appropriate referrals and completed tests in federally qualified health centers (FQHCs). This highlights an emerging role for pharmacists in primary care for chronic disease management.
Area of Science:
- Primary Care Medicine
- Clinical Pharmacy Practice
- Pulmonary Medicine
Background:
- Spirometry testing is crucial for diagnosing and managing respiratory conditions like chronic obstructive pulmonary disease (COPD).
- Identification and referral of high-risk patients for spirometry can be suboptimal in primary care settings.
- Federally Qualified Health Centers (FQHCs) serve diverse populations, necessitating efficient screening and diagnostic pathways.
Purpose of the Study:
- To evaluate the impact of proactive pharmacist identification of high-risk patients on spirometry referral and completion rates.
- To assess the effectiveness of pharmacist-led spirometry screening initiatives in an FQHC setting.
- To determine if pharmacist intervention improves appropriate diagnostic spirometry utilization.
Main Methods:
- A prospective, comparative study was conducted across intervention and control sites within an FQHC over 12 weeks.
- Pharmacists proactively recommended spirometry to eligible high-risk patients prior to their primary care provider (PCP) appointments at the intervention site.
- Chart reviews were performed at both sites to determine spirometry referral and completion rates among qualifying patients.
Main Results:
- A total of 190 patients were eligible for spirometry testing (125 intervention, 65 control).
- The percentage of spirometry referrals ordered was significantly higher at the intervention site (47.2%) compared to the control site (7.7%), P < .001.
- Spirometry test completion rates were also significantly higher in the intervention group (23.2%) versus the control group (3.1%), P < .001.
Conclusions:
- Proactive pharmacist identification of high-risk patients significantly increases appropriate spirometry referrals and test completion in FQHCs.
- Pharmacists can play a vital role in primary care by enhancing COPD management through increased spirometry utilization and patient counseling.
- This population health approach demonstrates an emerging, valuable role for pharmacists in primary care settings.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Inhaled Medications
Chronic Obstructive Pulmonary Disease-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

